Stephens & Co. Downgrades Univest Financial to Equal-Weight, Announces $30.5 Price Target
Stephens & Co. analyst Matt Breese downgrades Univest Financial (NASDAQ:UVSP) from Overweight to Equal-Weight and announces $30.5 price target.
Univest Financial Q3 EPS $0.71 Beats $0.66 Estimate
Univest Financial (NASDAQ:UVSP) reported quarterly earnings of $0.71 per share which beat the analyst consensus estimate of $0.66 by 7.58 percent. This is a 1.39 percent decrease over earnings of $0.72 per share from the
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 361 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 574 stocks hit new 52-week lows.
Univest Financial: Q2 Earnings Insights
Univest Financial (NASDAQ:UVSP) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:15 PM.
Here's what investors need to know about the announcement.
Univest Financial Q2 EPS $0.45 Misses $0.62 Estimate
Univest Financial (NASDAQ:UVSP) reported quarterly earnings of $0.45 per share which missed the analyst consensus estimate of $0.62 by 27.42 percent. This is a 36.62 percent decrease over earnings of $0.71 per share from
Earnings Scheduled For July 27, 2022
Companies Reporting Before The Bell
• Equinor (NYSE:EQNR) is projected to report earnings for its second quarter.
A Preview Of Univest Financial’s Earnings
Univest Financial (NASDAQ:UVSP) is set to give its latest quarterly earnings report on Wednesday, 2022-07-27. Here's what investors need to know before the announcement.
Analysts estimate that Univest Financial will report an earnings per share (EPS) of $0.62.
Raymond James Maintains Outperform on Univest Financial, Lowers Price Target to $29
Raymond James analyst William Wallace maintains Univest Financial (NASDAQ:UVSP) with a Outperform and lowers the price target from $31 to $29.
Raymond James Maintains Outperform on Univest Financial, Lowers Price Target to $31
Raymond James analyst William Wallace maintains Univest Financial (NASDAQ:UVSP) with a Outperform and lowers the price target from $34 to $31.